DHMYX
Price
$27.85
Change
-$0.28 (-1.00%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

DHMYX vs VMVAX

Header iconDHMYX vs VMVAX Comparison
Open Charts DHMYX vs VMVAXBanner chart's image
Diamond Hill Small-Mid Cap Y
Price$27.85
Change-$0.28 (-1.00%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DHMYX vs VMVAX Comparison Chart
Loading...
VS
DHMYX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHMYX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. DHMYX (1.38B). VMVAX pays higher dividends than DHMYX: VMVAX (2.14) vs DHMYX (1.27). DHMYX was incepted earlier than VMVAX: DHMYX (13 years) vs VMVAX (13 years). VMVAX is a more actively managed with annual turnover of: 22.00 vs. DHMYX (16.00). VMVAX has a lower initial minimum investment than DHMYX: VMVAX (3000) vs DHMYX (500000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. DHMYX (21.00). VMVAX return over 5 years is better than : 48.82 vs. DHMYX (30.14).
DHMYXVMVAXDHMYX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD9.00214.94660%
Front LoadN/AN/A-
Min. Initial Investment500000300016,667%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B30.5B5%
Annual Yield % from dividends1.272.1459%
Returns for 1 year21.0025.3583%
Returns for 3 years4.5420.7122%
Returns for 5 years30.1448.8262%
Returns for 10 years63.27100.8863%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio